Authors:
BOLWELL B
GOORMASTIC M
DANNLEY R
ANDRESEN S
OVERMOYER B
MENDEZ Z
KALAYCIOGLU M
DEMARS D
WISE K
POHLMAN B
Citation: B. Bolwell et al., G-CSF POST-AUTOLOGOUS PROGENITOR-CELL TRANSPLANTATION - A RANDOMIZED STUDY OF 5, 10, AND 16 MU-G KG/DAY/, Bone marrow transplantation, 19(3), 1997, pp. 215-219
Authors:
WALLER CF
MARAN A
PARANJAPE JM
LI GY
XIAO W
ZHANG K
KALAYCIOGLU M
TORRENCE PF
SILVERMAN RH
Citation: Cf. Waller et al., SPECIFIC DEGRADATION OF BCR ABL MESSENGER-RNA AND GROWTH SUPPRESSION OF CML CELLS BY 2-5A ANTISENSE OLIGONUCLEOTIDES/, Blood, 90(10), 1997, pp. 4020-4020
Authors:
TBAKHI A
SREENAN JJ
PETTAY JD
KALAYCIOGLU M
HOELTGE G
MILLER ML
TUBBS RR
Citation: A. Tbakhi et al., A COMPARATIVE-ANALYSIS OF INTERPHASE FLUORESCENCE IN-SITU HYBRIDIZATION (FISH) AND REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION (RT-PCR)FOR THE DETECTION OF THE BER ABL FUSION GENE IN CHRONIC MYELOGENOUS LEUKEMIA (CML) AND RELATED DISORDERS/, Laboratory investigation, 74(1), 1996, pp. 720-720
Authors:
KALAYCIOGLU M
COPELAN E
AVALOS B
KLEIN J
GOORMASTIC M
BOLWELL B
Citation: M. Kalaycioglu et al., SURVIVAL AFTER ABO-INCOMPATIBLE ALLOGENEIC BONE-MARROW TRANSPLANT AFTER A PREPARATIVE REGIMEN OF BUSULFAN AND CYCLOPHOSPHAMIDE, Bone marrow transplantation, 15(1), 1995, pp. 105-110
Authors:
KALAYCIOGLU M
KAVURU M
TUASON L
BOLWELL B
Citation: M. Kalaycioglu et al., EMPIRIC PREDNISONE THERAPY FOR PULMONARY TOXIC REACTION AFTER HIGH-DOSE CHEMOTHERAPY CONTAINING CARMUSTINE (BCNU), Chest, 107(2), 1995, pp. 482-487
Authors:
SHARMA S
ZUCCARO K
KALAYCIOGLU M
ANDRESEN S
LICHTIN A
POHLMAN B
LONG T
HUSSEIN MA
Citation: S. Sharma et al., PRE-MEDICATION (PM) FOR PLATELET (PLT) TRANSFUSION (TX) - A PROSPECTIVE-STUDY ON THE EFFICACY OF 4 COMMONLY USED REGIMENS, Blood, 86(10), 1995, pp. 1402-1402
Authors:
BOLWELL B
GOORMASTIC M
DANNLEY R
ANDRESEN S
OVERMOYER B
POHLMAN B
MENDEZ Z
KALAYCIOGLU M
DEMARS D
WISE K
Citation: B. Bolwell et al., G-CSF POST-AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) TRANSPLANT - A RANDOMIZED STUDY OF 5, 10, AND 16 MCG D/, Blood, 86(10), 1995, pp. 2465-2465
Authors:
GELLER RB
TARANTOLO S
POWELL BL
KALAYCIOGLU M
ZAKNOEN S
KLEIN L
GARRISON L
Citation: Rb. Geller et al., PHASE-II STUDY OF PIXY321 IN ELDERLY PATIENTS (PTS) WITH NEWLY-DIAGNOSED ACUTE MYELOCYTIC-LEUKEMIA (AML), Blood, 86(10), 1995, pp. 3026-3026
Authors:
KALAYCIOGLU M
FISHLEDER A
POHLMAN B
GOORMASTIC M
DANNLEY R
SANDS K
BAUCCO P
BOLWELL B
Citation: M. Kalaycioglu et al., LOWER NUMBERS OF CD 56-KILLER (NK) CELLS INFUSED AFTER SELECTIVE CD8+T-CELL DEPLETED (TCD) ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) ARE ASSOCIATED WITH IMPROVED SURVIVAL( NATURAL), Blood, 84(10), 1994, pp. 10000339-10000339
Authors:
BOLWELL B
KALAYCIOGLU M
POHLMAN B
BAUCCO P
LICHTIN A
ANDRESEN S
GOORMASTIC M
DANNLEY R
VUKOVICH K
FISHLEDER A
Citation: B. Bolwell et al., T-CELL DEPLETION (TCD) OF CD8-BASED PREPARATIVE REGIMENS( CELLS IS ASSOCIATED WITH AN INCREASED RISK OF GRAFT FAILURE, BUT NOT RELAPSE, IN CML USING BUSULFAN), Blood, 84(10), 1994, pp. 10000340-10000340
Authors:
GEWIRTZ A
KALAYCIOGLU M
BOLWELL B
GOORMASTIC M
FISHLEDER A
Citation: A. Gewirtz et al., RETICULIN CONTENT OF RECIPIENT BONE-MARROW DOES NOT AFFECT RATE OF ENGRAFTMENT IN ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 84(10), 1994, pp. 10000487-10000487
Authors:
POHLMAN B
DANLEY RA
KALAYCIOGLU M
LICHTIN AE
ANDRESEN SA
BOLWELL B
Citation: B. Pohlman et al., GROWTH-FACTOR MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS ARE SUFFICIENT TO SUSTAIN LONG-TERM HEMATOPOIESIS FOLLOWING MYELOABLATIVE CHEMOTHERAPY, Blood, 84(10), 1994, pp. 10000718-10000718
Authors:
BOLWELL B
DANNLEY R
ZGRABIK J
LICHTIN A
ANDRESEN S
POHLMAN B
TATE J
GOORMASTIC M
SANDS K
KALAYCIOGLU M
Citation: B. Bolwell et al., ANALYSIS OF FACTORS INFLUENCING THE YIELD OF BONE-MARROW HARVEST IN THE OUT PATIENT SETTING, Blood, 84(10), 1994, pp. 10000733-10000733
Authors:
KALAYCIOGLU M
COPELAN E
AVALOS B
KLEIN J
LICHTIN A
ANDRESEN S
FISHLEDER A
TUASON L
BOLWELL B
Citation: M. Kalaycioglu et al., MAJOR ABO-INCOMPATIBLE ALLOGENEIC BONE-MARROW TRANSPLANTATION AFTER TREATMENT WITH BUSULFAN AND CYCLOPHOSPHAMIDE - DECREASED RISK OF LEUKEMIC RELAPSE, Experimental hematology, 21(8), 1993, pp. 1108-1108
Citation: M. Kalaycioglu et B. Bolwell, EOSINOPHILIA AFTER BUSULFAN AND CYCLOPHOSPHAMIDE FOLLOWED BY ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 82(10), 1993, pp. 10000632-10000632